• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎干扰素-α再治疗期间肾病综合征急性起病

Acute onset of nephrotic syndrome during interferon-alpha retreatment for chronic active hepatitis C.

作者信息

Nishimura Satoshi, Miura Hideaki, Yamada Haruki, Shinoda Toshio, Kitamura Shigehiro, Miura Yasusada

机构信息

Department of Internal Medicine, Social Insurance Chuo General Hospital, 3-22-1 Hyakunin-cho, Shinjuku-ku, Tokyo 169-0073, Japan.

出版信息

J Gastroenterol. 2002;37(10):854-8. doi: 10.1007/s005350200141.

DOI:10.1007/s005350200141
PMID:12424571
Abstract

A 57-year-old woman was scheduled to receive recombinant interferon-alpha retreatment for chronic active hepatitis C. During the course of therapy, the patient showed rapid onset of oliguria, dizziness, edema, and a pre-shock state. She was subsequently admitted to hospital and was diagnosed as having nephrotic syndrome. After admission, albumin-dominant proteinuria persisted despite the discontinuation of interferon therapy. Light microscopy of a renal needle biopsy specimen showed interstitial lymphoid cell infiltration, but no marked changes of the glomeruli and no staining for immunoglobulin or complement. Electron microscopy showed diffuse effacement of the glomerular epithelial foot processes, leading to a diagnosis of minimal change nephrotic syndrome with interstitial nephritis. Proteinuria resolved after the initiation of oral prednisolone therapy (1 mg/kg per day). The number of patients with chronic hepatitis C requiring interferon retreatment is increasing rapidly. We herein report this rare case of acute onset of nephrotic syndrome during interferon-alpha retreatment.

摘要

一名57岁女性计划接受重组干扰素α再次治疗慢性活动性丙型肝炎。在治疗过程中,患者迅速出现少尿、头晕、水肿和休克前期状态。随后她被收治入院,被诊断为肾病综合征。入院后,尽管停用了干扰素治疗,但以白蛋白为主的蛋白尿持续存在。肾穿刺活检标本的光镜检查显示间质淋巴细胞浸润,但肾小球无明显变化,免疫球蛋白或补体无染色。电镜检查显示肾小球上皮足突弥漫性消失,诊断为微小病变型肾病综合征合并间质性肾炎。口服泼尼松龙治疗(每日1mg/kg)后蛋白尿消失。需要再次接受干扰素治疗的慢性丙型肝炎患者数量正在迅速增加。我们在此报告这例干扰素α再次治疗期间急性发作肾病综合征的罕见病例。

相似文献

1
Acute onset of nephrotic syndrome during interferon-alpha retreatment for chronic active hepatitis C.慢性丙型肝炎干扰素-α再治疗期间肾病综合征急性起病
J Gastroenterol. 2002;37(10):854-8. doi: 10.1007/s005350200141.
2
[Nephrotic syndrome and acute interstitial nephritis after phenylbutazone].[保泰松所致肾病综合征及急性间质性肾炎]
Schweiz Med Wochenschr. 1985 Nov 2;115(44):1551-5.
3
A woman with chronic hepatitis C infection and nephrotic syndrome who developed multiple renal lesions after interferon alfa therapy.
Am J Kidney Dis. 2004 Sep;44(3):567-73.
4
Interferon induced glomerular disease in a patient with chronic hepatitis C.一名慢性丙型肝炎患者的干扰素诱导性肾小球疾病
Med J Malaysia. 2003 Oct;58(4):594-6.
5
Nephrotic syndrome and acute interstitial nephritis associated with the use of diclofenac.肾病综合征及与使用双氯芬酸相关的急性间质性肾炎。
Wien Klin Wochenschr. 1999 Jul 9;111(13):523-4.
6
Nephrotic syndrome associated with lithium therapy.
Clin Nephrol. 1981 May;15(5):267-71.
7
Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.初次干扰素治疗后出现生化反应的慢性丙型肝炎患者复发后干扰素再治疗的疗效
J Gastroenterol. 2004;39(5):455-60. doi: 10.1007/s00535-003-1323-4.
8
Retreatment with human leukocyte interferon alpha of chronic hepatitis C, recurring after a first cycle with recombinant interferon.慢性丙型肝炎在首次使用重组干扰素治疗一个周期后复发,用人白细胞干扰素α进行再治疗。
Ital J Gastroenterol Hepatol. 1998 Apr;30(2):234-5.
9
Cockayne syndrome with recurrent acute tubulointerstitial nephritis.
Pathol Int. 2006 Nov;56(11):678-82. doi: 10.1111/j.1440-1827.2006.02029.x.
10
Steroid-sensitive nephrotic syndrome associated with positive C1q immunofluorescence.伴有C1q免疫荧光阳性的类固醇敏感性肾病综合征
Clin Exp Nephrol. 2004 Sep;8(3):266-9. doi: 10.1007/s10157-004-0282-2.

引用本文的文献

1
Single cell analysis identified IFN signaling activation contributes to the pathogenesis of pediatric steroid-sensitive nephrotic syndrome.单细胞分析表明,干扰素信号激活有助于小儿激素敏感性肾病综合征的发病机制。
Biomark Res. 2025 May 24;13(1):77. doi: 10.1186/s40364-025-00790-2.
2
Minimal change disease in treatment-naïve hepatitis C virus infection: A case report and literature review.初治丙型肝炎病毒感染中的微小病变病:一例病例报告及文献综述
Clin Nephrol Case Stud. 2025 Jan 10;13:1-7. doi: 10.5414/CNCS111506. eCollection 2025.
3
Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases.
基于指数富集技术的配体系统进化及适体应用:传染病精准医学的最新进展与挑战
Front Bioeng Biotechnol. 2021 Aug 10;9:704077. doi: 10.3389/fbioe.2021.704077. eCollection 2021.
4
Broad spectrum of interferon-related nephropathies-glomerulonephritis, systemic lupus erythematosus-like syndrome and thrombotic microangiopathy: A case report and review of literature.干扰素相关肾病的广泛谱系——肾小球肾炎、系统性红斑狼疮样综合征和血栓性微血管病:一例病例报告及文献综述
World J Nephrol. 2019 Nov 12;8(7):109-117. doi: 10.5527/wjn.v8.i7.109.
5
Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.潜伏型干扰素 alpha 2b 的开发作为一种安全的治疗方法,用于治疗丙型肝炎病毒感染。
Sci Rep. 2019 Jul 26;9(1):10867. doi: 10.1038/s41598-019-47074-y.
6
Side effects of cytokines approved for therapy.已获批用于治疗的细胞因子的副作用。
Drug Saf. 2014 Nov;37(11):921-43. doi: 10.1007/s40264-014-0226-z.
7
De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).慢性丙型肝炎干扰素治疗后新发膜增生性肾炎(病例研究与文献综述)
Dig Dis Sci. 2014 Mar;59(3):691-5. doi: 10.1007/s10620-013-2959-4. Epub 2013 Dec 8.
8
Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.用 IFN- {alpha}、IFN- {beta}或 IFN- {gamma}治疗与局灶性节段性肾小球硬化症的塌陷有关。
Clin J Am Soc Nephrol. 2010 Apr;5(4):607-15. doi: 10.2215/CJN.07311009. Epub 2010 Mar 4.
9
Renal adverse effects of interferon-alpha.α-干扰素的肾脏不良反应。
Drug Saf. 2005;28(7):647. doi: 10.2165/00002018-200528070-00007.